Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cesar Rodriguez

Showing results (191-200 of 256) with videos related to

Pageof 26
Sort By:
Cancer|November 14, 2023
Incidence, timing, and management of infections in patients receiving teclistamab for the treatment of relapsed/refractory multiple myeloma in the MajesTEC-1 studyAjay K Nooka, Cesar Rodriguez, María Victoria Mateos, et al.
Nature Methods|March 12, 2013
Quantitative estimation of activity and quality for collections of functional genetic elementsVivek K Mutalik, Joao C Guimaraes, Guillaume Cambray, et al.
Current Medical Research and Opinion|August 23, 2024
Real-world experience with clinical management of talquetamab in relapsed/refractory multiple myeloma: a qualitative study of US healthcare providersCarolina Schinke, Binod Dhakal, Sandra Mazzoni, et al.
Leukemia & Lymphoma|July 21, 2025
BCMA-targeting BiTE molecule AMG 420 in relapsed or refractory multiple myeloma: a phase 1b open-label expansion studyCesar Rodriguez, Tulio Rodriguez, Alain Kentos, et al.
Bone Marrow Transplantation|October 19, 2022
Bridging advanced myeloma patients to subsequent treatments and clinical trials with classical chemotherapy and stem cell supportTarek H Mouhieddine, Erin Moshier, Santiago Thibaud, et al.
Bone Marrow Transplantation|May 3, 2025
Extramedullary disease but not paraskeletal disease portends inferior outcomes after CAR T cell therapy in multiple myelomaDarren Pan, Tarek H Mouhieddine, Tianxiang Sheng, et al.
Environmental Entomology|April 19, 2018
Multistate Comparison of Attractants and the Impact of Fruit Development Stage on Trapping Drosophila suzukii (Diptera: Drosophilidae) in Raspberry and BlueberryBenjamin D Jaffe, Alina Avanesyan, Harit K Bal, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|April 8, 2022
Ionic Combisomes: A New Class of Biomimetic Vesicles to Fuse with LifeAnna M Wagner, Jonas Quandt, Dominik Söder, et al.
Bone Marrow Transplantation|March 30, 2026
Baseline absolute lymphocyte count, C-reactive protein, and ferritin predict CAR T cell-related toxicities and outcomes in multiple myelomaDarren Pan, Tarek H Mouhieddine, Tianxiang Sheng, et al.
Blood Cancer Discovery|September 28, 2023
IVIg Use Associated with Ten-Fold Reduction of Serious Infections in Multiple Myeloma Patients Treated with Anti-BCMA Bispecific AntibodiesGuido Lancman, Kian Parsa, Krzysztof Kotlarz, et al.
Pageof 26

Showing results (191-200 of 256) with videos related to

Sort By:
Pageof 26
Cancer|November 14, 2023
Incidence, timing, and management of infections in patients receiving teclistamab for the treatment of relapsed/refractory multiple myeloma in the MajesTEC-1 studyAjay K Nooka, Cesar Rodriguez, María Victoria Mateos, et al.
Nature Methods|March 12, 2013
Quantitative estimation of activity and quality for collections of functional genetic elementsVivek K Mutalik, Joao C Guimaraes, Guillaume Cambray, et al.
Current Medical Research and Opinion|August 23, 2024
Real-world experience with clinical management of talquetamab in relapsed/refractory multiple myeloma: a qualitative study of US healthcare providersCarolina Schinke, Binod Dhakal, Sandra Mazzoni, et al.
Leukemia & Lymphoma|July 21, 2025
BCMA-targeting BiTE molecule AMG 420 in relapsed or refractory multiple myeloma: a phase 1b open-label expansion studyCesar Rodriguez, Tulio Rodriguez, Alain Kentos, et al.
Bone Marrow Transplantation|October 19, 2022
Bridging advanced myeloma patients to subsequent treatments and clinical trials with classical chemotherapy and stem cell supportTarek H Mouhieddine, Erin Moshier, Santiago Thibaud, et al.
Bone Marrow Transplantation|May 3, 2025
Extramedullary disease but not paraskeletal disease portends inferior outcomes after CAR T cell therapy in multiple myelomaDarren Pan, Tarek H Mouhieddine, Tianxiang Sheng, et al.
Environmental Entomology|April 19, 2018
Multistate Comparison of Attractants and the Impact of Fruit Development Stage on Trapping Drosophila suzukii (Diptera: Drosophilidae) in Raspberry and BlueberryBenjamin D Jaffe, Alina Avanesyan, Harit K Bal, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|April 8, 2022
Ionic Combisomes: A New Class of Biomimetic Vesicles to Fuse with LifeAnna M Wagner, Jonas Quandt, Dominik Söder, et al.
Bone Marrow Transplantation|March 30, 2026
Baseline absolute lymphocyte count, C-reactive protein, and ferritin predict CAR T cell-related toxicities and outcomes in multiple myelomaDarren Pan, Tarek H Mouhieddine, Tianxiang Sheng, et al.
Blood Cancer Discovery|September 28, 2023
IVIg Use Associated with Ten-Fold Reduction of Serious Infections in Multiple Myeloma Patients Treated with Anti-BCMA Bispecific AntibodiesGuido Lancman, Kian Parsa, Krzysztof Kotlarz, et al.
Pageof 26